全球 HIV 快速檢測試劑盒市場——展望與預測 (2023-2028)

從 2022 年到 2028 年，全球 HIV 快速檢測試劑盒市場預計將以 2.70% 的複合年增長率增長。 艾滋病毒感染者人數的增加和艾滋病毒自我檢測意識的提高是推動市場增長的因素。

本報告研究和分析了全球 HIV 快速檢測試劑盒市場，提供了市場規模和預測、驅動因素、競爭格局等。

內容

第一章研究方法論

第二章研究目的

第三章研究過程

第 4 章範圍

第 5 章報告前提條件和注意事項

第 6 章市場概述

第 7 章：關鍵考慮因素

第8章介紹

第9章市場機會和趨勢

第 10 章市場增長驅動因素

第11章市場約束

第 12 章市場狀況

• 市場概覽
  • 討論：通過技術
  • 討論：按樣本類型
  • 討論：按分銷渠道
  • 地區：按地區
• 市場規模和預測
• 五力分析

第13章技術

• 市場概況和增長引擎
• 市場概覽
• 側流免疫分析
• 免疫過濾

第 14 章樣本類型

• 市場概況和增長引擎
• 市場概覽
• 血液
• 口腔液
• 尿液

第 15 章分銷渠道

• 市場概況和增長引擎
• 市場概覽
• 離線
• 在線

第16章區域

• 市場概況和增長引擎
• 地理概覽

第十七章北美

• 市場概覽
• 市場規模和預測
• 技術
• 樣本類型
• 分銷渠道
• 主要國家
  • 美國：市場規模和預測
  • 加拿大：市場規模和預測

第18章亞太地區

• 市場概覽
• 市場規模和預測
• 技術
• 樣本類型
• 分銷渠道
• 主要國家
  • 中國：市場規模和預測
  • 印度：市場規模和預測
  • 印度尼西亞：市場規模和預測
  • 泰國：市場規模和預測
  • 越南：市場規模和預測

第19章中東和非洲

• 市場概覽
• 市場規模和預測
• 技術
• 樣本類型
• 分銷渠道
• 主要國家
  • 南非：市場規模和預測
  • 莫桑比克：市場規模和預測
  • 肯尼亞：市場規模和預測
  • 尼日利亞：市場規模和預測
  • 坦桑尼亞：市場規模和預測

第 20 章：歐洲

• 市場概覽
• 市場規模和預測
• 技術
• 樣本類型
• 分銷渠道
• 主要國家
  • 法國：市場規模和預測
  • 意大利：市場規模和預測
  • 烏克蘭：市場規模和預測
  • 葡萄牙：市場規模和預測
  • 俄羅斯：市場規模和預測

第21章拉丁美洲

• 市場概覽
• 市場規模和預測
• 技術
• 樣本類型
• 分銷渠道
• 主要國家
  • 巴西：市場規模和預測
  • 墨西哥：市場規模和預測
  • 哥倫比亞：市場規模和預測

第22章競爭格局

• 比賽總結
• 市場份額分析
  • 雅培
  • BIO-RAD 實驗室
  • 生物梅裡埃
  • 化學診斷學
  • 歐舒科技

第23章主要公司簡介

• 雅培
• BIO-RAD 實驗室
• 生物梅裡埃
• 化學診斷學
• 歐舒科技

第 24 章其他知名供應商

• ATOMO DIAGNOSTICS
• ACCUBIOTECH
• BIOLYTICAL LABORATORIES
• BIOSYNEX
• CUPID LIMITED
• HUMAN
• INTEC
• J. MITRA & CO
• MERIL LIFE SCIENCES
• MP BIOMEDICALS
• MEDSOURCE OZONE BIOMEDICALS
• NANJING SYNTHGENE MEDICAL TECHNOLOGY
• PREMIER MEDICAL
• SD BIOSENSOR
• KHB (SHANGHAI KEHUA BIO-ENGINEERING)
• TURKLAB A.S.
• TRINITY BIOTECH
• WANTAI BIOPHARMA
• WONDFO

第25章報告總結

• 重要說明
• 戰略建議

第 26 章定量總結

第27章附錄

The global HIV rapid test kits market size is expected to grow at a CAGR of 2.70% during 2022 to 2028

In the U.S., HIV testing is vital and integral to HIV prevention and management. The knowledge about HIV infection is increasing rapidly in the country, accelerating the high demand for HIV self-testing. In recent years, the significant patient population in the country has gone through routine medical checkups, which includes HIV test. It increases the knowledge about HIV testing and care in the country and propels the market growth.

Human Immunodeficiency Virus (HIV) is a viral infection that attacks the body's immune system and does not have effective care treatment across the world. It leads to acquired immunodeficiency syndrome (AIDS). Globally, more than 38.4 million people are living with HIV infection, among which Africa accounted for the higher patient population. HIV is one of the leading causes of death in the world. The Joint United Nations Programme on HIV/AIDS and WHO are two major health organizations working towards increasing awareness among people about HIV, HIV infection, and associated preventive measures. These two organizations aim to reduce around 90% HIV burden of the world by 2030. Based on that, several countries joined these initiatives to improve their national HIV status. HIV self-testing (HIVST) is one of the major strategies addressed by WHO and UNIAIDS to overcome the HIV burden. These steps lead to an increase in demand for HIVST that directly impact the HIV rapid test kits market.

MARKET TRENDS & OPPORTUNITIES

Raise of Next-Generation HIV Test Technology

The rise of fourth-generation rapid test kits has become more popular in recent years. This technology is more accurate and reliable for screening the acute HIV presence in the sample. The 4th generation HIV test easily detects HIV in lesser time and more accurately than other generation technologies. Such factors allow individuals to get a cure sooner and potentially prevent the spread of infection to others. One of the leading HIV rapid test kit market players, OraSure technologies, got approval for a home test kit known as "OraQuick In-Home HIV Test," which gives results in 20 to 40 minutes.

Increasing HIV Self-Testing Associated Government Policies

The UNAID and WHO are working together towards HIV prevention. Several strategic implementations are implemented worldwide to increase HIV self-testing (HIVST) and to understand the actual burden of HIV/AIDS globally. Eastern and Southern Africa, and Western and Central Europe & North America are the regions that implemented several HIVST policies that deliver HIV rapid test kits market growth opportunities. Due to the increasing acceptance of HIVST, the knowledge and awareness about HIV increased among the people, resulting in many people looking for easy HIV testing.

New Paradigm of Digital Support In HIV Self-Testing

The COVID-19 pandemic led to several service disruptions in the supply of HIV diagnoses and treatments, which led to falling short of the UNAIDS 2030 target. However, the COVID-19 pandemic accelerated the application of digital tools in health services. The incorporation of digital tools gave a new paradigm in HIV care management. The application of digital tools in HIV management is increasing that expected to fuel the HIV rapid test kits market. According to The Lancet research, the adoption and innovation of digital HIV self-testing tools have been increasing recently, and website-based innovations are becoming more popular.

Increasing Targeted Patient Population

Around 15,000,000 people acquired HIV in 2020. In 2022, more than 38 million people were expected to live with HIV. This further results in increasing HIV preventive measures, which include increasing the number of people undergoing HIV tests through self-test kits. In high-infection regions such as Africa, Europe, and Asian countries, the demand for HIV testing is increasing year by year, which drives the application rate of HIV rapid test kits and propels market growth.

Increasing Awareness about HIV Self-Testing

Most countries are making significant progress in reducing the HIV burden with UNAIDS and WHO. Globally, around 95% of people living with HIV are expected to be aware of their HIV status by 2025. Further, the increasing prevalence of HIV, the awareness among HIV-infected and non-infected people in developed and developing countries is increasing rapidly. In developed countries, HIV infection awareness increased through various government and health authorities' programs working as support to improve knowledge about HIV self-testing solutions. The increasing access to HIV rapid test kits through health authorities and vendor activities and the acceptance of self-testing kits for HIV management are increasing simultaneously, fueling the HIV rapid test kits market growth.

SEGMENTATION INSIGHTS

INSIGHTS BY TECHNOLOGY

The global HIV rapid test kits market based on technology is segmented into lateral flow immunoassay and immunofixation. The lateral flow immunoassay segment accounted for a 78.25% market share in 2021. A higher number of HIV rapid test kit products are available and approved by various health authorities in the market and are developed by the lateral flow immunoassay technology. This technology delivers several advantaged and accurate results in HIV rapid testing. One of the major reasons for increasing preference towards the usage of HIV rapid test kits is their immediate results. The quicker results will help healthcare professionals to make treatment plans in the market. Quicker diagnosis of the disease will help the healthcare providers to safeguard the patients and to take enough preventive measures to reduce the spread of the disease in the market.

Segmentation by Technology

• Lateral Flow Immunoassay
• Immunofiltration

INSIGHTS BY SAMPLE TYPE

The blood sample type segment accounted for a higher 63.46% market share in the global HIV rapid test kits market and dominated the other segments. Blood sample-based HIV rapid test kits are highly recommended by medical professionals due to their potential to carry HIV antibodies in high proportion. In HIV testing, blood samples (plasma, serum, DBS) are highly preferred for HIV rapid testing. Blood samples carry higher concentrations of HIV antibodies than oral (saliva) samples. These sample-based HIV rapid testing found antibodies using a drop of blood from the fingertip. In addition to the individuals, healthcare settings also use HIV rapid test kits that drive blood sample segmental growth. In addition, HIV rapid test kits are distributed to patients through clinical laboratories, research centers, and community-based organizations.

Segmentation by Sample Type

• Blood
• Oral Fluid
• Urine

INSIGHTS BY DISTRIBUTION CHANNELS

The offline segment dominates the distribution channels and accounts for a 66.70% global HIV rapid test kits market share. Offline sales channels included medical shops, pharmacies, hospitals, clinics, associated pharmacies, and pharma retailers. Offline sales channels are the first point of resource for HIV testing in LMICs. In most developing countries, people choose medical pharmacies as the first care point to buy HIV rapid test kits. Easy access and availability with the convenience of buyers are the major factors that drive major sales through offline channels. In low- and middle-income countries, drug shops are critical in healthcare provisions, where they are often the first point of care access for medical solutions. Drug shops are the best alternative to conventional facility-based HIV testing and counseling, and offline stores offer significant advantages in those regions for HIV rapid test kits. Consumers avoid a longer wait and potential clinical staff and associated charges.

Segmentation by Distribution Channels

• Offline
• Online

GEOGRAPHICAL ANALYSIS

North America dominates the global HIV rapid test kits market accounting for a 31.06% market share. The factors that propel the market growth in the region are the higher HIV prevalence and the increasing awareness among the key patient populations. The government support and funding for HIV management as preventive measures drive the region's significant market growth. More than 3.8 million people in North America are estimated for HIV in 2022. The awareness about HIV self-testing is significantly high in the US, while Canada is showing progressive growth for HIV self-testing.

The Europe HIV rapid test kits market was valued at USD 158.77 million in 2022. It is estimated that the rate and number of new diagnoses of HIV infection are continuously increasing in East Europe and are growing rapidly, though from a much lower base in Central Europe region.

Segmentation by Geography

• North America
  • US
  • Canada
• Europe
  • France
  • Italy
  • Ukraine
  • Portugal
  • Russia
• APAC
  • China
  • India
  • Indonesia
  • Thailand
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Columbia
• Middle East & Africa
  • South Africa
  • Mozambique
  • Kenya
  • Nigeria
  • Tanzania

VENDOR LANDSCAPE

The global HIV rapid test kits market has many global, regional, and domestic players that offer a comprehensive product portfolio of HIV rapid test kits. Some global market players have acquired high industry penetration with a broader distribution network and business strategies. Also, some companies collaborate with WHO and UNAIDS to increase the increasing rate of HIV self-testing by supporting HIV rapid test kits. In 2022, WHO partnered with the Clinton Health Access Initiative (CHAI), Wondfo Biotech Company, and MedAccess. This partnership makes available HIV-self-test kits for only USD 1 in the public sector of LMICs. This is expected to increase the high industry competition among leading market players. The inorganic growth strategies of leading market players create entry barriers for many small and emerging players.

Key Company Profiles

• Abbott
• Bio-Rad Laboratories
• BIOMERIEUX
• Chembio Diagnostics
• OraSure Technologies

Other Prominent Vendors

• Atomo Diagnostics
• AccuBioTech
• bioLytical Laboratories
• Biosynex
• Cupid Limited
• DIALAB
• HUMAN
• INTEC
• J. Mitra & Co
• Meril Life Sciences
• MP Biomedicals
• Medsource Ozone Biomedicals
• Nanjing Synthgene Medical Technology
• Premier Medical
• SD Biosensor
• KHB (Shanghai Kehua Bio-Engineering co., Ltd.)
• Turklab A.S.
• Trinity Biotech
• Wantai BioPharma
• Wondfo

KEY QUESTIONS ANSWERED:

• 1. How big is the HIV rapid test kits market?
• 2. What is the growth rate of the HIV rapid test kits market?
• 3. Which region holds the most significant global HIV rapid test kits market share?
• 4. What are the growing trends in the HIV rapid test kits market?
• 5. Which are the key companies in the global HIV rapid test kits market?

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

• 4.1 MARKET DEFINITION
  • 4.1.1 INCLUSIONS
  • 4.1.2 EXCLUSIONS
  • 4.1.3 MARKET ESTIMATION CAVEATS
• 4.2 BASE YEAR
• 4.3 SCOPE OF THE STUDY
  • 4.3.1 MARKET BY TECHNOLOGY
  • 4.3.2 MARKET BY SAMPLE TYPE
  • 4.3.3 MARKET BY DISTRIBUTION CHANNELS
  • 4.3.4 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

• 5.1 KEY CAVEATS
• 5.2 CURRENCY CONVERSION
• 5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 PREMIUM INSIGHTS

• 7.1 OVERVIEW

8 INTRODUCTION

• 8.1 OVERVIEW

9 MARKET OPPORTUNITIES & TRENDS

• 9.1 INTRODUCTION OF NEXT GENERATION HIV RAPID TEST KITS
• 9.2 INCREASE IN HIV SELF-TESTING BY GOVERNMENT BODIES
• 9.3 DIGITAL SUPPORT FOR HIV SELF-TESTING

10 MARKET GROWTH ENABLERS

• 10.1 INCREASING HIV PATIENT POPULATION
• 10.2 INCREASED RESOURCES AVAILABILITY AND FUNDING FOR HIV MANAGEMENT
• 10.3 INCREASED AWARENESS OF HIV SELF-TESTING

11 MARKET RESTRAINTS

• 11.1 INCREASING INCIDENCES OF FALSE NEGATIVES
• 11.2 LIMITATIONS & CHALLENGES ASSOCIATED WITH HIV TESTING
• 11.3 LOW ACCESSIBLITY & LACK OF AWARENESS FOR HIVST

12 MARKET LANDSCAPE

• 12.1 MARKET OVERVIEW
  • 12.1.1 INSIGHTS BY TECHNOLOGY
  • 12.1.2 INSIGHTS BY SAMPLE TYPE
  • 12.1.3 INSIGHTS BY DISTRIBUTION CHANNELS
  • 12.1.4 INSIGHTS BY GEOGRAPHY
• 12.2 MARKET SIZE & FORECAST
• 12.3 FIVE FORCES ANALYSIS
  • 12.3.1 THREAT OF NEW ENTRANTS
  • 12.3.2 BARGAINING POWER OF SUPPLIERS
  • 12.3.3 BARGAINING POWER OF BUYERS
  • 12.3.4 THREAT OF SUBSTITUTES
  • 12.3.5 COMPETITIVE RIVALRY

13 TECHNOLOGY

• 13.1 MARKET SNAPSHOT & GROWTH ENGINE
• 13.2 MARKET OVERVIEW
• 13.3 LATERAL FLOW IMMUNOASSAY
  • 13.3.1 MARKET OVERVIEW
  • 13.3.2 MARKET SIZE & FORECAST
  • 13.3.3 MARKET BY GEOGRAPHY
• 13.4 IMMUNOFILTRATION
  • 13.4.1 MARKET OVERVIEW
  • 13.4.2 MARKET SIZE & FORECAST
  • 13.4.3 MARKET BY GEOGRAPHY

14 SAMPLE TYPE

• 14.1 MARKET SNAPSHOT & GROWTH ENGINE
• 14.2 MARKET OVERVIEW
• 14.3 BLOOD
  • 14.3.1 MARKET OVERVIEW
  • 14.3.2 MARKET SIZE & FORECAST
  • 14.3.3 MARKET BY GEOGRAPHY
• 14.4 ORAL FLUID
  • 14.4.1 MARKET OVERVIEW
  • 14.4.2 MARKET SIZE & FORECAST
  • 14.4.3 MARKET BY GEOGRAPHY
• 14.5 URINE
  • 14.5.1 MARKET OVERVIEW
  • 14.5.2 MARKET SIZE & FORECAST
  • 14.5.3 MARKET BY GEOGRAPHY

15 DISTRIBUTION CHANNEL

• 15.1 MARKET SNAPSHOT & GROWTH ENGINE
• 15.2 MARKET OVERVIEW
• 15.3 OFFLINE
  • 15.3.1 MARKET OVERVIEW
  • 15.3.2 MARKET SIZE & FORECAST
  • 15.3.3 MARKET BY GEOGRAPHY
• 15.4 ONLINE
  • 15.4.1 MARKET OVERVIEW
  • 15.4.2 MARKET SIZE & FORECAST
  • 15.4.3 MARKET BY GEOGRAPHY

16 GEOGRAPHY

• 16.1 MARKET SNAPSHOT & GROWTH ENGINE
• 16.2 GEOGRAPHIC OVERVIEW

17 NORTH AMERICA

• 17.1 MARKET OVERVIEW
• 17.2 MARKET SIZE & FORECAST
• 17.3 TECHNOLOGY
  • 17.3.1 MARKET SIZE & FORECAST
• 17.4 SAMPLE TYPE
  • 17.4.1 MARKET SIZE & FORECAST
• 17.5 DISTRIBUTION CHANNELS
  • 17.5.1 MARKET SIZE & FORECAST
• 17.6 KEY COUNTRIES
  • 17.6.1 US: MARKET SIZE & FORECAST
  • 17.6.2 CANADA: MARKET SIZE & FORECAST

18 APAC

• 18.1 MARKET OVERVIEW
• 18.2 MARKET SIZE & FORECAST
• 18.3 TECHNOLOGY
  • 18.3.1 MARKET SIZE & FORECAST
• 18.4 SAMPLE TYPE
  • 18.4.1 MARKET SIZE & FORECAST
• 18.5 DISTRIBUTION CHANNELS
  • 18.5.1 MARKET SIZE & FORECAST
• 18.6 KEY COUNTRIES
  • 18.6.1 CHINA: MARKET SIZE & FORECAST
  • 18.6.2 INDIA: MARKET SIZE & FORECAST
  • 18.6.3 INDONESIA: MARKET SIZE & FORECAST
  • 18.6.4 THAILAND: MARKET SIZE & FORECAST
  • 18.6.5 VIETNAM: MARKET SIZE & FORECAST

19 MIDDLE EAST & AFRICA

• 19.1 MARKET OVERVIEW
• 19.2 MARKET SIZE & FORECAST
• 19.3 TECHNOLOGY
  • 19.3.1 MARKET SIZE & FORECAST
• 19.4 SAMPLE TYPE
  • 19.4.1 MARKET SIZE & FORECAST
• 19.5 DISTRIBUTION CHANNELS
  • 19.5.1 MARKET SIZE & FORECAST
• 19.6 KEY COUNTRIES
  • 19.6.1 SOUTH AFRICA: MARKET SIZE & FORECAST
  • 19.6.2 MOZAMBIQUE: MARKET SIZE & FORECAST
  • 19.6.3 KENYA: MARKET SIZE & FORECAST
  • 19.6.4 NIGERIA: MARKET SIZE & FORECAST
  • 19.6.5 TANZANIA: MARKET SIZE & FORECAST

20 EUROPE

• 20.1 MARKET OVERVIEW
• 20.2 MARKET SIZE & FORECAST
• 20.3 TECHNOLOGY
  • 20.3.1 MARKET SIZE & FORECAST
• 20.4 SAMPLE TYPE
  • 20.4.1 MARKET SIZE & FORECAST
• 20.5 DISTRIBUTION CHANNELS
  • 20.5.1 MARKET SIZE & FORECAST
• 20.6 KEY COUNTRIES
  • 20.6.1 FRANCE: MARKET SIZE & FORECAST
  • 20.6.2 ITALY: MARKET SIZE & FORECAST
  • 20.6.3 UKRAINE: MARKET SIZE & FORECAST
  • 20.6.4 PORTUGAL: MARKET SIZE & FORECAST
  • 20.6.5 RUSSIA: MARKET SIZE & FORECAST

21 LATIN AMERICA

• 21.1 MARKET OVERVIEW
• 21.2 MARKET SIZE & FORECAST
• 21.3 TECHNOLOGY
  • 21.3.1 MARKET SIZE & FORECAST
• 21.4 SAMPLE TYPE
  • 21.4.1 MARKET SIZE & FORECAST
• 21.5 DISTRIBUTION CHANNELS
  • 21.5.1 MARKET SIZE & FORECAST
• 21.6 KEY COUNTRIES
  • 21.6.1 BRAZIL: MARKET SIZE & FORECAST
  • 21.6.2 MEXICO: MARKET SIZE & FORECAST
  • 21.6.3 COLOMBIA: MARKET SIZE & FORECAST

22 COMPETITIVE LANDSCAPE

• 22.1 COMPETITION OVERVIEW
• 22.2 MARKET SHARE ANALYSIS
  • 22.2.1 ABBOTT
  • 22.2.2 BIO-RAD LABORATORIES
  • 22.2.3 BIOMERIEUX
  • 22.2.4 CHEMBIO DIAGNOSTICS
  • 22.2.5 ORASURE TECHNOLOGIES

23 KEY COMPANY PROFILES

• 23.1 ABBOTT
  • 23.1.1 BUSINESS OVERVIEW
  • 23.1.2 PRODUCT OFFERINGS
  • 23.1.3 KEY STRATEGIES
  • 23.1.4 KEY STRENGTHS
  • 23.1.5 KEY OPPORTUNITIES
• 23.2 BIO-RAD LABORATORIES
  • 23.2.1 BUSINESS OVERVIEW
  • 23.2.2 PRODUCT OFFERINGS
  • 23.2.3 KEY STRATEGIES
  • 23.2.4 KEY STRENGTHS
  • 23.2.5 KEY OPPORTUNITIES
• 23.3 BIOMERIEUX
  • 23.3.1 BUSINESS OVERVIEW
  • 23.3.2 PRODUCT OFFERINGS
  • 23.3.3 KEY STRATEGIES
  • 23.3.4 KEY STRENGTHS
  • 23.3.5 KEY OPPORTUNITIES
• 23.4 CHEMBIO DIAGNOSTICS
  • 23.4.1 BUSINESS OVERVIEW
  • 23.4.2 PRODUCT OFFERINGS
  • 23.4.3 KEY STRATEGIES
  • 23.4.4 KEY STRENGTHS
  • 23.4.5 KEY OPPORTUNITIES
• 23.5 ORASURE TECHNOLOGIES
  • 23.5.1 BUSINESS OVERVIEW
  • 23.5.2 PRODUCT OFFERINGS
  • 23.5.3 KEY STRATEGIES
  • 23.5.4 KEY STRENGTHS
  • 23.5.5 KEY OPPORTUNITIES

24 OTHER PROMINENT VENDORS

• 24.1 ATOMO DIAGNOSTICS
  • 24.1.1 BUSINESS OVERVIEW
  • 24.1.2 PRODUCT OFFERINGS
• 24.2 ACCUBIOTECH
  • 24.2.1 BUSINESS OVERVIEW
  • 24.2.2 PRODUCT OFFERINGS
• 24.3 BIOLYTICAL LABORATORIES
  • 24.3.1 BUSINESS OVERVIEW
  • 24.3.2 PRODUCT OFFERINGS
• 24.4 BIOSYNEX
  • 24.4.1 BUSINESS OVERVIEW
  • 24.4.2 PRODUCT OFFERINGS
• 24.5 CUPID LIMITED
  • 24.5.1 BUSINESS OVERVIEW
  • 24.5.2 PRODUCT OFFERINGS
• 24.6 HUMAN
  • 24.6.1 BUSINESS OVERVIEW
  • 24.6.2 PRODUCT OFFERINGS
• 24.7 INTEC
  • 24.7.1 BUSINESS OVERVIEW
  • 24.7.2 PRODUCT OFFERINGS
• 24.8 J. MITRA & CO
  • 24.8.1 BUSINESS OVERVIEW
  • 24.8.2 PRODUCT OFFERINGS
• 24.9 MERIL LIFE SCIENCES
  • 24.9.1 BUSINESS OVERVIEW
  • 24.9.2 PRODUCT OFFERINGS
• 24.10 MP BIOMEDICALS
  • 24.10.1 BUSINESS OVERVIEW
  • 24.10.2 PRODUCT OFFERINGS
• 24.11 MEDSOURCE OZONE BIOMEDICALS
  • 24.11.1 BUSINESS OVERVIEW
  • 24.11.2 PRODUCT OFFERINGS
• 24.12 NANJING SYNTHGENE MEDICAL TECHNOLOGY
  • 24.12.1 BUSINESS OVERVIEW
  • 24.12.2 PRODUCT OFFERINGS
• 24.13 PREMIER MEDICAL
  • 24.13.1 BUSINESS OVERVIEW
  • 24.13.2 PRODUCT OFFERINGS
• 24.14 SD BIOSENSOR
  • 24.14.1 BUSINESS OVERVIEW
  • 24.14.2 PRODUCT OFFERINGS
• 24.15 KHB (SHANGHAI KEHUA BIO-ENGINEERING)
  • 24.15.1 BUSINESS OVERVIEW
  • 24.15.2 PRODUCT OFFERINGS
• 24.16 TURKLAB A.S.
  • 24.16.1 BUSINESS OVERVIEW
  • 24.16.2 PRODUCT OFFERINGS
• 24.17 TRINITY BIOTECH
  • 24.17.1 BUSINESS OVERVIEW
  • 24.17.2 PRODUCT OFFERINGS
• 24.18 WANTAI BIOPHARMA
  • 24.18.1 BUSINESS OVERVIEW
  • 24.18.2 PRODUCT OFFERINGS
• 24.19 WONDFO
  • 24.19.1 BUSINESS OVERVIEW
  • 24.19.2 PRODUCT OFFERINGS

25 REPORT SUMMARY

• 25.1 KEY TAKEAWAYS
• 25.2 STRATEGIC RECOMMENDATIONS

26 QUANTITATIVE SUMMARY

• 26.1 MARKET BY GEOGRAPHY
• 26.2 MARKET BY TECHNOLOGY
• 26.3 MARKET BY SAMPLE TYPE
• 26.4 MARKET BY DISTRIBUTION CHANNELS
• 26.5 TECHNOLOGY: MARKET BY GEOGRAPHY
  • 26.5.1 LATERAL FLOW IMMUNOASSAY: MARKET BY GEOGRAPHY
  • 26.5.2 IMMUNOFILTRATION: MARKET BY GEOGRAPHY
• 26.6 SAMPLE TYPE: MARKET BY GEOGRAPHY
  • 26.6.1 BLOOD SAMPLE TYPE: MARKET BY GEOGRAPHY
  • 26.6.2 ORAL FLUID SAMPLE TYPE: MARKET BY GEOGRAPHY
  • 26.6.3 URINE SAMPLE TYPE: MARKET BY GEOGRAPHY
• 26.7 DISTRIBUTION CHANNELS: MARKET BY GEOGRAPHY
  • 26.7.1 OFFLINE DISTRIBUTION CHANNELS: MARKET BY GEOGRAPHY
  • 26.7.2 ONLINE DISTRIBUTION CHANNELS: MARKET BY GEOGRAPHY

27 APPENDIX

• 27.1 ABBREVIATIONS

LIST OF EXHIBITS

• EXHIBIT 1 SEGMENTATION OF GLOBAL HIV RAPID TEST KITS MARKET
• EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2022
• EXHIBIT 3 EVOLUTION OF HIC RAPID TEST KITS
• EXHIBIT 4 IMPACT OF INTRODUCTION OF NEXT GENERATION HIV RAPID TEST KITS
• EXHIBIT 5 ADVANTAGES OF FOURTH GENERATION HIV RAPID TEST KITS:
• EXHIBIT 6 IMPACT OF INCREASE IN HIV SELF-TESTING BY GOVERNMENT BODIES
• EXHIBIT 7 NATIONAL HIV SELF-TESTING POLICY & IMPLEMENTATION BY REGION (2020)
• EXHIBIT 8 COUNTRIES IMPLEMENTING HIVST IN WORKPLACES
• EXHIBIT 9 IMPACT OF DIGITAL SUPPORT FOR HIV SELF-TESTING
• EXHIBIT 10 DIGITAL HIV SELF-TESTING INNOVATIONS 2021
• EXHIBIT 11 IMPACT OF INCREASING HIV PATIENT POPULATION
• EXHIBIT 12 GLOBAL DISTRIBUTION OF NEW HIV INFECTIONS BY POPULATION 2021
• EXHIBIT 13 NUMBER OF HIV TESTS & TEST POSITIVITY RATE IN SUB-SAHARAN AFRICA REGION (2017-2021)
• EXHIBIT 14 GLOBAL HIV INFECTION AND ASSOCIATED STATISTICS 2021
• EXHIBIT 15 HIV PATIENT POPULATION BY REGION 2021 (MILLION)
• EXHIBIT 16 IMPACT OF INCREASED RESOURCES AVAILABILITY AND FUNDING FOR HIV MANAGEMENT
• EXHIBIT 17 AVAILABILITY OF RESOURCES FOR HIV MANAGEMENT IN LMICS 2010 TO 2021 ($ BILLION)
• EXHIBIT 18 FUNDING PROPOSED BY SEVERAL AGENCIES IN THE US FOR HIV MANAGEMENT 2022-2023
• EXHIBIT 19 IMPACT OF INCREASED AWARENESS OF HIV SELF-TESTING
• EXHIBIT 20 ESTIMATED AND PROJECTED HIV SELF-TESTING REQUIREMENTS FOR LMICS FROM 2020 TO 2025 (MILLION)
• EXHIBIT 21 IMPACT OF INCREASING INCIDENCES OF FALSE NEGATIVES
• EXHIBIT 22 IMPACT OF LIMITATIONS & CHALLENGES ASSOCIATED WITH HIV TESTING
• EXHIBIT 23 REASONS FOR SKIPPING OF HIV TESTS
• EXHIBIT 24 IMPACT OF LOW ACCESSIBILITY & LACK OF AWARENESS FOR HIVST
• EXHIBIT 25 GLOBAL HIV RAPID TEST KITS MARKET BY TECHNOLOGY 2020 & 2028
• EXHIBIT 26 GLOBAL HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2020 & 2028
• EXHIBIT 27 GLOBAL HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2020 & 2028
• EXHIBIT 28 GLOBAL HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2020 & 2028
• EXHIBIT 29 GLOBAL HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 30 FIVE FORCES ANALYSIS 2022
• EXHIBIT 31 INCREMENTAL GROWTH BY TECHNOLOGY 2022 & 2028
• EXHIBIT 32 GLOBAL HIV RAPID TEST KITS MARKET BY TECHNOLOGY 2022-2028
• EXHIBIT 33 GLOBAL HIV RAPID TEST KITS MARKET BY TECHNOLOGY: MARKET OVERVIEW
• EXHIBIT 34 GLOBAL HIV RAPID TEST KITS MARKET BY TECHNOLOGY: INCREMENTAL GROWTH
• EXHIBIT 35 GLOBAL HIV RAPID TEST KITS MARKET BY TECHNOLOGY: ABSOLUTE GROWTH
• EXHIBIT 36 GLOBAL LATERAL FLOW IMMUNOASSAY HIV RAPID TEST KITS MARKET: INCREMENT GROWTH & ABSOLUTE GROWTH
• EXHIBIT 37 GLOBAL LATERAL FLOW IMMUNOASSAY HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 38 GLOBAL IMMUNO-FILTRATION HIV RAPID TEST KITS MARKET: INCREMENT GROWTH & ABSOLUTE GROWTH
• EXHIBIT 39 GLOBAL IMMUNOFILTRATION HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 40 INCREMENTAL GROWTH BY SAMPLE TYPE 2022 & 2028
• EXHIBIT 41 GLOBAL HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2022-2028
• EXHIBIT 42 GLOBAL HIV RAPID TEST KITS MARKET: SAMPLE TYPE OVERVIEW
• EXHIBIT 43 GLOBAL HIV RAPID TEST KITS MARKET BY SAMPLE TYPE: INCREMENTAL GROWTH
• EXHIBIT 44 GLOBAL HIV RAPID TEST KITS MARKET BY SAMPLE TYPE: ABSOLUTE GROWTH
• EXHIBIT 45 GLOBAL BLOOD SAMPLE HIV RAPID TEST KITS MARKET: INCREMENT GROWTH & ABSOLUTE GROWTH
• EXHIBIT 46 GLOBAL BLOOD SAMPLE HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 47 GLOBAL ORAL FLUID-BASED HIV RAPID TEST KITS MARKET: INCREMENT GROWTH & ABSOLUTE GROWTH
• EXHIBIT 48 GLOBAL ORAL FLUID-BASED HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 49 GLOBAL URINE SAMPLE-BASED HIV RAPID TEST KITS MARKET: INCREMENT GROWTH & ABSOLUTE GROWTH
• EXHIBIT 50 GLOBAL URINE SAMPLE-BASED HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 51 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2022 & 2028
• EXHIBIT 52 GLOBAL HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2022-2028
• EXHIBIT 53 GLOBAL HIV RAPID TEST KITS MARKET: DISTRIBUTION CHANNELS OVERVIEW
• EXHIBIT 54 GLOBAL HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS: INCREMENTAL GROWTH
• EXHIBIT 55 GLOBAL HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS: ABSOLUTE GROWTH
• EXHIBIT 56 GLOBAL OFFLINE HIV RAPID TEST KITS MARKET: INCREMENT GROWTH & ABSOLUTE GROWTH
• EXHIBIT 57 GLOBAL OFFLINE HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 58 GLOBAL ONLINE HIV RAPID TEST KITS MARKET: INCREMENT GROWTH & ABSOLUTE GROWTH
• EXHIBIT 59 GLOBAL ONLINE HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 60 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028
• EXHIBIT 61 GLOBAL HIV RAPID TESTING MARKET BY GEOGRAPHY 2022-2028
• EXHIBIT 62 GLOBAL HIV RAPID TEST KITS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
• EXHIBIT 63 GLOBAL HIV RAPID TEST KITS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
• EXHIBIT 64 GLOBAL HIV RAPID TEST KITS MARKET: GEOGRAPHY OVERVIEW
• EXHIBIT 65 NORTH AMERICA HIV RAPID TEST KITS MARKET: KEY COUNTRIES
• EXHIBIT 66 NORTH AMERICA HIV RAPID TEST KITS MARKET: INCREMENT GROWTH & ABSOLUTE GROWTH
• EXHIBIT 67 NORTH AMERICA HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 68 INCREMENTAL GROWTH IN NORTH AMERICA 2022 & 2028
• EXHIBIT 69 US HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 70 PROGRESS TOWARD GLOBAL HIV MANAGEMENT TARGET IN CANADA2020-2025
• EXHIBIT 71 CANADA HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 72 APAC HIV RAPID TEST KITS MARKET: KEY COUNTRIES
• EXHIBIT 73 APAC HIV RAPID TEST KITS MARKET: INCREMENT GROWTH & ABSOLUTE GROWTH
• EXHIBIT 74 APAC HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 75 INCREMENTAL GROWTH IN APAC 2022 & 2028
• EXHIBIT 76 CHINA HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 77 INDIA KEY HIV STATISTICS 2021
• EXHIBIT 78 INDIA HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 79 TOTAL HIV CASES IN INDONESIA 2010-2021
• EXHIBIT 80 INDONESIA HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 81 THAILAND HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 82 VIETNAM: KEY FACTS ON HIV IN 2021
• EXHIBIT 83 VIETNAM HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 84 MIDDLE EAST & AFRICA HIV RAPID TEST KITS MARKET: KEY COUNTRIES
• EXHIBIT 85 MIDDLE EAST & AFRICA NATIONAL HIVST POLICIES & IMPLEMENTATION 2020 (REGION)
• EXHIBIT 86 MIDDLE EAST & AFRICA HIV RAPID TEST KITS MARKET: INCREMENT GROWTH & ABSOLUTE GROWTH
• EXHIBIT 87 MIDDLE EAST & AFRICA HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 88 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2022 & 2028
• EXHIBIT 89 SOUTH AFRICA HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 90 MOZAMBIQUE HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 91 CHALLENGES IN KENYA PHARMACIES WITH DISTRIBUTION OF HIV SELF-TEST KITS
• EXHIBIT 92 KENYA HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 93 NIGERIA: HIV PREVALENCE 2021
• EXHIBIT 94 NIGERIA HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 95 HIVST CONFIRMED SPECIFIC VOLUME IN TANZANIA 2020
• EXHIBIT 96 TANZANIA HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 97 ESTIMATED NEW HIV INFECTIONS & NEW DIAGNOSIS IN WHO EUROPEAN REGION 2012 TO 2021
• EXHIBIT 98 EUROPE HIV RAPID TEST KITS MARKET: INCREMENT GROWTH & ABSOLUTE GROWTH
• EXHIBIT 99 EUROPE HIV RAPID TEST KITS MARKET: KEY COUNTRIES
• EXHIBIT 100 SPAIN HIV STATISTICS 2021
• EXHIBIT 101 GERMANY: PEOPLE LIVING WITH HIV AND NEW HIV INFECTION CASES 2015 TO 2020
• EXHIBIT 102 EUROPE HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 103 INCREMENTAL GROWTH IN EUROPE 2022 & 2028
• EXHIBIT 104 FRANCE HIV PATIENT POPULATION STATISTICS IN 2021
• EXHIBIT 105 FRANCE HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 106 HIV PREVALENCE & ASSOCIATED STATISTICS IN ITALY 2021
• EXHIBIT 107 ITALY HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 108 UKRAINE: PROGRESS TOWARD ACHIEVING UNAIDS GOALS (2017-2019)
• EXHIBIT 109 UKRAINE HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 110 PORTUGAL HIV CASES FROM 2010 TO 2021
• EXHIBIT 111 PORTUGAL HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 112 RUSSIA HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 113 LATIN AMERICA HIV RAPID TEST KITS MARKET: INCREMENT GROWTH & ABSOLUTE GROWTH
• EXHIBIT 114 LATIN AMERICA HIV RAPID TEST KITS MARKET: KEY COUNTRIES
• EXHIBIT 115 LATIN AMERICA HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 116 INCREMENTAL GROWTH IN LATIN AMERICA 2022 & 2028
• EXHIBIT 117 AWARENESS, ACCEPTABILITY, & WILLINGNESS OF HEALTHCARE PROFESSIONALS OFFERING HIVST IN BRAZIL 2019-2020
• EXHIBIT 118 BRAZIL HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 119 MEXICO: HIV STATISTICS 2021
• EXHIBIT 120 MEXICO HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 121 HIV & AIDS ESTIMATIONS IN COLOMBIA 2021
• EXHIBIT 122 COLOMBIA HIV RAPID TEST KITS MARKET 2022-2028 ($ MILLION)
• EXHIBIT 123 VENDORS OFFERING HIV RAPID TEST KITS: MARKET DOMINANCE ANALYSIS
• EXHIBIT 124 VENDORS OFFERING HIV RAPID TEST KITS: CAPABILITIES AND EXPERTISE ASSESSMENT
• EXHIBIT 125 ABBOTT ANNUAL REVENUE (2019-2021) ($ MILLION)
• EXHIBIT 126 ORASURE TECHNOLOGIES ANNUAL REVENUE 2019-2021 ($ MILLION)
• EXHIBIT 127 ORASURE TECHNOLOGIES HIV PORTFOLIO REVENUE 2019-2021 ($ MILLION)

LIST OF TABLES

• TABLE 1 KEY CAVEATS
• TABLE 2 CURRENCY CONVERSION 2015-2022
• TABLE 3 SOME FOURTH GENERATION HIV RAPID TEST KITS
• TABLE 4 FLUORESCENT CHROMATOGRAPHY TECHNOLOGY-BASED HIV RAPID TEST KITS
• TABLE 5 SOME LEADING MARKET PLAYERS WITH LATERAL FLOW IMMUNOASSAY-BASED HIV RAPID TEST KITS
• TABLE 6 LATERAL FLOW IMMUNOASSAY MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
• TABLE 7 LATERAL FLOW IMMUNOASSAY MARKET BY GEOGRAPHY 2022-2028 (%)
• TABLE 8 IMMUNOFILTRATION TECHNOLOGY-BASED HIV RAPID TEST KITS
• TABLE 9 IMMUNOFILTRATION HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
• TABLE 10 IMMUNOFILTRATION HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 (%)
• TABLE 11 BLOOD SAMPLE-BASED HIV RAPID TEST KITS & MANUFACTURING COMPANIES
• TABLE 12 BLOOD SAMPLE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
• TABLE 13 BLOOD SAMPLE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 (%)
• TABLE 14 ORAL SAMPLE-BASED HIV RAPID TEST KITS
• TABLE 15 ORAL FLUID-BASED HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
• TABLE 16 ORAL FLUID-BASED HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 (%)
• TABLE 17 SOME URINE SAMPLE BASED HIV RAPID TEST KITS AVAILABLE IN GLOBAL MARKET
• TABLE 18 URINE SAMPLE TYPE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
• TABLE 19 ORAL FLUID SAMPLE TYPE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 (%)
• TABLE 20 OFFLINE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
• TABLE 21 OFFLINE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 (%)
• TABLE 22 ONLINE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
• TABLE 23 ONLINE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 (%)
• TABLE 24 HIV BURDEN IN NORTH AMERICA 2021
• TABLE 25 NORTH AMERICA HIV RAPID TEST KITS MARKET BY TECHNOLOGY 2022-2028 ($ MILLION)
• TABLE 26 NORTH AMERICA HIV RAPID TEST KITS MARKET BY TECHNOLOGY 2022-2028 (%)
• TABLE 27 NORTH AMERICA HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2022-2028 ($ MILLION)
• TABLE 28 NORTH AMERICA HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2022-2028 (%)
• TABLE 29 NORTH AMERICA HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2022-2028 ($ MILLION)
• TABLE 30 NORTH AMERICA HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2022-2028 (%)
• TABLE 31 APAC HIV RAPID TEST KITS MARKET BY TECHNOLOGY 2022-2028 ($ MILLION)
• TABLE 32 APAC HIV RAPID TEST KITS MARKET BY TECHNOLOGY 2022-2028 (%)
• TABLE 33 APAC HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2022-2028 ($ MILLION)
• TABLE 34 APAC HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2022-2028 (%)
• TABLE 35 APAC HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2022-2028 ($ MILLION)
• TABLE 36 APAC HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2022-2028 (%)
• TABLE 37 FUNDING FOR SUSTAINABLE HIV SERVICES FOR MOROCCO, TUNISIA, EGYPT, JORDAN, AND LEBANON
• TABLE 38 MIDDLE EAST & AFRICA HIV RAPID TEST KITS MARKET BY TECHNOLOGY 2022-2028 ($ MILLION)
• TABLE 39 MIDDLE EAST & AFRICA HIV RAPID TEST KITS MARKET BY TECHNOLOGY 2022-2028 (%)
• TABLE 40 MIDDLE EAST & AFRICA HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2022-2028 ($ MILLION)
• TABLE 41 MIDDLE EAST & AFRICA HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2022-2028 (%)
• TABLE 42 MIDDLE EAST & AFRICA HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2022-2028 ($ MILLION)
• TABLE 43 MIDDLE EAST & AFRICA HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2022-2028 (%)
• TABLE 44 LIST OF LEADING EUROPEAN COUNTRIES WITH HIGHEST HIV CASES (2022)
• TABLE 45 SOME HIV RAPID TEST KITS USED AS HOME HIV TEST KITS IN UK
• TABLE 46 EUROPE HIV RAPID TEST KITS MARKET BY TECHNOLOGY 2022-2028 ($ MILLION)
• TABLE 47 EUROPE HIV RAPID TEST KITS MARKET BY TECHNOLOGY 2022-2028 (%)
• TABLE 48 EUROPE HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2022-2028 ($ MILLION)
• TABLE 49 EUROPE HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2022-2028 (%)
• TABLE 50 EUROPE HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2022-2028 ($ MILLION)
• TABLE 51 EUROPE HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2022-2028 (%)
• TABLE 52 RUSSIA: REGULATION ON ENTRY, RESIDENCE, AND STAY FOR PEOPLE LIVING WITH HIV (2021)
• TABLE 53 LATIN AMERICA HIV RAPID TEST KITS MARKET BY TECHNOLOGY 2022-2028 ($ MILLION)
• TABLE 54 LATIN AMERICA HIV RAPID TEST KITS MARKET BY TECHNOLOGY 2022-2028 (%)
• TABLE 55 LATIN AMERICA HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2022-2028 ($ MILLION)
• TABLE 56 LATIN AMERICA HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2022-2028 (%)
• TABLE 57 LATIN AMERICA HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2022-2028 ($ MILLION)
• TABLE 58 LATIN AMERICA HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2022-2028 (%)
• TABLE 59 ABBOTT: MAJOR PRODUCT OFFERINGS
• TABLE 60 BIO-RAD LABORATORIES: MAJOR PRODUCT OFFERINGS
• TABLE 61 BIOMERIEUX: MAJOR PRODUCT OFFERINGS
• TABLE 62 CHEMBIO DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
• TABLE 63 ORASURE TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
• TABLE 64 ATOMO DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
• TABLE 65 ACCUBIOTECH: MAJOR PRODUCT OFFERINGS
• TABLE 66 BIOLYTICAL LABORATORIES: MAJOR PRODUCT OFFERINGS
• TABLE 67 BIOSYNEX: MAJOR PRODUCT OFFERINGS
• TABLE 68 CUPID LIMITED: MAJOR PRODUCT OFFERINGS
• TABLE 69 HUMAN: MAJOR PRODUCT OFFERINGS
• TABLE 70 INTEC: MAJOR PRODUCT OFFERINGS
• TABLE 71 J. MITRA & CO.: MAJOR PRODUCT OFFERINGS
• TABLE 72 MERIL LIFE SCIENCES: MAJOR PRODUCT OFFERINGS
• TABLE 73 MP BIOMEDICALS: MAJOR PRODUCT OFFERINGS
• TABLE 74 MEDSOURCE OZONE BIOMEDICALS: MAJOR PRODUCT OFFERINGS
• TABLE 75 NANJING SYNTHGENE MEDICAL TECHNOLOGY: MAJOR PRODUCT OFFERINGS
• TABLE 76 PREMIER MEDICAL: MAJOR PRODUCT OFFERINGS
• TABLE 77 SD BIOSENSOR: MAJOR PRODUCT OFFERINGS
• TABLE 78 KHB: MAJOR PRODUCT OFFERINGS
• TABLE 79 TURKLAB A.S.: MAJOR PRODUCT OFFERINGS
• TABLE 80 TRINITY BIOTECH: MAJOR PRODUCT OFFERINGS
• TABLE 81 WANTAI BIOPHARMA: MAJOR PRODUCT OFFERINGS
• TABLE 82 WONDFO: MAJOR PRODUCT OFFERINGS
• TABLE 83 GLOBAL HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
• TABLE 84 GLOBAL HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 (%)
• TABLE 85 GLOBAL HIV RAPID TEST KITS MARKET BY TECHNOLOGY 2022-2028 ($ MILLION)
• TABLE 86 GLOBAL HIV RAPID TEST KITS MARKET BY TECHNOLOGY 202-2028 (%)
• TABLE 87 GLOBAL HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2022-2028 ($ MILLION)
• TABLE 88 GLOBAL HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2022-2028 (%)
• TABLE 89 GLOBAL HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2022-2028 ($ MILLION)
• TABLE 90 GLOBAL HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2022-2028 (%)
• TABLE 91 LATERAL FLOW IMMUNOASSAY HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
• TABLE 92 LATERAL FLOW IMMUNOASSAY HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 (%)
• TABLE 93 IMMUNOFILTRATION HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
• TABLE 94 IMMUNOFILTRATION HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 (%)
• TABLE 95 BLOOD SAMPLE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
• TABLE 96 BLOOD SAMPLE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 (%)
• TABLE 97 ORAL FLUID SAMPLE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
• TABLE 98 ORAL FLUID SAMPLE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 (%)
• TABLE 99 URINE SAMPLE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
• TABLE 100 URINE SAMPLE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 (%)
• TABLE 101 OFFLINE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
• TABLE 102 OFFLINE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 (%)
• TABLE 103 ONLINE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
• TABLE 104 ONLINE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022-2028 (%)